While Tirzepatide is generally well tolerated, it may cause side effects such as nausea, diarrhea, and decreased appetite, which are typically mild to moderate
June 1, 2026: More Lawsuits Filed in GLP-1 Litigation as Eli Lilly Asks for Lawsuit Dismissal The company that makes Trulicity, Eli Lilly, has asked for lawsuits in the GLP-1 to be dismissed and asked for testimonies from plaintiffs experts to be excluded
Novo's newly acquired drug is a clear potential competitor to retatrutide because it similarly uses a three-pronged approach to promoting weight loss and regulating blood sugar
Injection to drops conversion Going from injections to drops typically requires a higher milligram dose to maintain similar blood levels
If youre dealing with unpredictable bathroom habits or sudden urgency, this one helps bring everything back to neutral
Think about what that means in practical terms